Patents by Inventor David Corey

David Corey has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 12067256
    Abstract: A technique is configured to provide various data protection schemes, such as replication and erasure coding, for data blocks of volumes served by storage nodes of a cluster configured to perform deduplication of the data blocks. Additionally, the technique is configured to ensure that each deduplicated data block complies with data redundancy guarantees of the data protection schemes, while improving storage space of the storage nodes. In order to satisfy the data integrity guarantees while improving available storage space, the storage nodes perform periodic garbage collection for data blocks to optimize storage in accordance with currently applicable data protection schemes.
    Type: Grant
    Filed: September 16, 2022
    Date of Patent: August 20, 2024
    Assignee: NetApp, Inc.
    Inventors: Christopher Clark Corey, Daniel David McCarthy, Sneheet Kumar Mishra, Austino Nicholas Longo
  • Patent number: 12063992
    Abstract: The presently disclosed subject matter relates generally to a treatment garment for use in clothed radiation treatment and diagnosis procedures, and methods of using the garment.
    Type: Grant
    Filed: April 24, 2023
    Date of Patent: August 20, 2024
    Assignee: The Moses H. Cone Memorial Hospital Operating Corporation
    Inventors: Benjamin Jeremiah Sintay, Sudhakar Puvvada, Thomas Lane Hayes, David Brian Wiant, Nicholas Corey Koch
  • Publication number: 20240247859
    Abstract: An apparatus for cryostorage and manipulation of a plurality of container units includes a cryochamber having a cryo-access port. The cryochamber is electrically cooled at cryogenic temperatures. A unit holder is located inside the cryochamber and is configured to hold a plurality of container units. A user access area is provided for selectively permitting access to a chosen container unit by an authenticated user who has been authenticated by the apparatus. A motive grasper is provided for selectively removing the chosen container unit from the cryochamber through the cryo-access port, and selectively placing the chosen container unit into the user access area.
    Type: Application
    Filed: April 2, 2024
    Publication date: July 25, 2024
    Inventors: Gil Bradford Van Bokkelen, Rakesh Ramachandran, Christopher Robert Bruns, Christopher John Hayes, John A. Corey, Troy M. Coolidge, Bruce E. Frohman, Joseph Gordon, Thomas R. Ruth, Jacob T. Williams, Gregory E. Kramer, Nathan A. Abel, David J. Copeland, Matthew R. Gill, Steven F. Shane
  • Publication number: 20240229029
    Abstract: Described are compounds and methods useful for the treatment and investigation of Friedreich's Ataxia.
    Type: Application
    Filed: September 20, 2023
    Publication date: July 11, 2024
    Applicant: The Board of Regents of The University of Texas System
    Inventors: David COREY, Liande LI
  • Publication number: 20240141348
    Abstract: Provided herein are compositions and methods for reducing expression of C9orf72 transcripts in cells containing expanded intronic GGGGCC regions, including those in subjects having or at risk of developing amyotrophic lateral sclerosis (ALS) and frontotemporal dementia (FTD).
    Type: Application
    Filed: October 19, 2023
    Publication date: May 2, 2024
    Applicant: The Board of Regents of The University of Texas System
    Inventors: David COREY, Jiaxin HU
  • Publication number: 20240132889
    Abstract: Described are compounds and methods useful for the treatment and investigation of Friedreich's Ataxia.
    Type: Application
    Filed: September 19, 2023
    Publication date: April 25, 2024
    Applicant: The Board of Regents of The University of Texas System
    Inventors: David COREY, Liande LI
  • Patent number: 11840690
    Abstract: Provided herein are compositions and methods for reducing expression of C9orf72 transcripts in cells containing expanded intronic GGGGCC regions, including those in subjects having or at risk of developing amyotrophic lateral sclerosis (ALS) and frontotemporal dementia (FTD).
    Type: Grant
    Filed: November 17, 2021
    Date of Patent: December 12, 2023
    Assignee: The Board of Regents of The University of Texas System
    Inventors: David Corey, Jiaxin Hu
  • Patent number: 11795457
    Abstract: Described are compounds and methods useful for the treatment and investigation of Friedreich's Ataxia.
    Type: Grant
    Filed: September 27, 2021
    Date of Patent: October 24, 2023
    Assignee: The Board of Regents of The University of Texas System
    Inventors: David Corey, Liande Li
  • Patent number: 11663313
    Abstract: Systems and methods for authenticating a peripheral device prior to allowing the peripheral device access to components and data stored on user equipment. In some examples, the user equipment may include an authorization component that is configured to physically decouple a hardware interface from other components of the user equipment until the authorization component is able to authenticate the peripheral device. Both authorized peripheral devices and the user equipment may be provisioned with authorization data and/or credentials from a system outside the control of the individual users of the user equipment.
    Type: Grant
    Filed: September 23, 2020
    Date of Patent: May 30, 2023
    Assignee: T-Mobile USA, Inc.
    Inventors: Michael Bishop, Shawn David Corey
  • Publication number: 20230020192
    Abstract: Disclosed herein are compounds and methods for modulating C9orf72 transcript. Such compounds and methods are useful to treat, prevent, or ameliorate neurodegenerative diseases in an individual in need thereof.
    Type: Application
    Filed: February 4, 2022
    Publication date: January 19, 2023
    Applicants: IONIS PHARMACEUTICALS, INC., BOARD OF REGENTS OF THE UNIVERSITY OF TEXAS SYSTEM
    Inventors: Thazha P. PRAKASH, Frank RIGO, David COREY
  • Patent number: 11459564
    Abstract: Certain embodiments are directed to methods and compounds for increasing FXN. Such methods and compounds are useful for increasing expression of FXN in cells and animals.
    Type: Grant
    Filed: December 21, 2018
    Date of Patent: October 4, 2022
    Assignees: IONIS PHARMACEUTICALS, INC., THE BOARD OF REGENTS OF THE UNIVERSITY OF TEXAS SYSTEM
    Inventors: Frank Rigo, Thazha P. Prakash, David Corey
  • Publication number: 20220114268
    Abstract: Systems and methods for encrypting and decrypting data sent to and received from a peripheral device physically coupled to a hardware interface of a user equipment. In some examples, the user equipment may include an encrypting/decryption component that is configured to physically between a hardware interface of the user equipment and the other components of the user equipment. The encrypting/decryption component may be configured to receive a plurality of encryption/decryption schemes from a remote system. The encrypting/decryption component may select and apply one or more of the plurality of encryption/decryption schemes to data being downloaded and/or uploaded to the peripheral device.
    Type: Application
    Filed: October 12, 2020
    Publication date: April 14, 2022
    Inventors: Michael Bishop, Shawn David Corey
  • Publication number: 20220108004
    Abstract: Described herein are techniques for performing a trusted execution environment (TEE) detection of systemic malware in a computing system that hosts the TEE. As described, the techniques may include a TEE obtaining data from one or more subsystems of a computing system that hosts the TEE. The TEE is configured to execute components in isolation from the one or more subsystems of the computing system. Based on the data obtained, the TEE detects systemic malware on the one or more subsystems of the computing system. In response to the detected malware, the TEE reports the detection of malware on the one or more subsystems of the computing system.
    Type: Application
    Filed: October 6, 2020
    Publication date: April 7, 2022
    Inventors: Shawn David Corey, Michael David Bishop
  • Publication number: 20220092167
    Abstract: Systems and methods for authenticating a peripheral device prior to allowing the peripheral device access to components and data stored on user equipment. In some examples, the user equipment may include an authorization component that is configured to physically decouple a hardware interface from other components of the user equipment until the authorization component is able to authenticate the peripheral device. Both authorized peripheral devices and the user equipment may be provisioned with authorization data and/or credentials from a system outside the control of the individual users of the user equipment.
    Type: Application
    Filed: September 23, 2020
    Publication date: March 24, 2022
    Inventors: Michael Bishop, Shawn David Corey
  • Publication number: 20220073918
    Abstract: Provided herein are compositions and methods for reducing expression of C9orf72 transcripts in cells containing expanded intronic GGGGCC regions, including those in subjects having or at risk of developing amyotrophic lateral sclerosis (ALS) and frontotemporal dementia (FTD).
    Type: Application
    Filed: November 17, 2021
    Publication date: March 10, 2022
    Applicant: The Board of Regents of The University of Texas System
    Inventors: David COREY, Jiaxin HU
  • Patent number: 11260073
    Abstract: Disclosed herein are compounds and methods for modulating C9orf72 transcript. Such compounds and methods are useful to treat, prevent, or ameliorate neurodegenerative diseases in an individual in need thereof.
    Type: Grant
    Filed: November 2, 2016
    Date of Patent: March 1, 2022
    Assignees: IONIS PHARMACEUTICALS, INC., BOARD OF REGENTS OF THE UNIVERSITY OF TEXAS SYSTEM
    Inventors: Thazha P. Prakash, Frank Rigo, David Corey
  • Publication number: 20220017903
    Abstract: Described are compounds and methods useful for the treatment and investigation of Friedreich's Ataxia.
    Type: Application
    Filed: September 27, 2021
    Publication date: January 20, 2022
    Applicant: The Board of Regents of The University of Texas System
    Inventors: David COREY, Liande LI
  • Patent number: 11133983
    Abstract: Technologies for using edge devices in a cellular network as compute nodes to participate in a blockchain network are described. A cellular network may provision one or more edge devices in communication with the cellular network to instantiate a virtual machine on the edge device to act as a compute node. The cellular network may submit a bid to solve a blockchain hash function using the compute nodes and may instruct the edge to solve the blockchain hash function.
    Type: Grant
    Filed: December 14, 2018
    Date of Patent: September 28, 2021
    Assignee: T-Mobile USA, Inc.
    Inventors: Ahmad Arash Obaidi, Shawn David Corey, Andrew Lee Watts
  • Publication number: 20210087559
    Abstract: Certain embodiments are directed to methods and compounds for increasing FXN. Such methods and compounds are useful for increasing expression of FXN in cells and animals.
    Type: Application
    Filed: December 21, 2018
    Publication date: March 25, 2021
    Inventors: Frank RIGO, Thazha P. PRAKASH, David COREY
  • Patent number: 10848942
    Abstract: In a wireless communication network such as a cellular network, cellular devices may receive over-the-air (OTA) configuration commands that specify requested device configuration settings. For example, an OTA configuration command may be a binary short message service (SMS) message specifying a configuration parameter and a requested value of the configuration parameter. Upon receiving an OTA configuration command, the cellular device refers to a blockchain that specifies permissible values for various configuration parameters. If a requested configuration parameter value is not indicated by the blockchain to be permissible, the cellular device disregards the OTA configuration command and refuses to implement the requested setting. The cellular device may periodically retrieve updates to the blockchain and may attempt to validate any updated blocks, based on previously validated blocks. If the updates cannot be validated, the cellular device may decline to implement any requested configuration settings.
    Type: Grant
    Filed: January 8, 2020
    Date of Patent: November 24, 2020
    Assignee: T-Mobile USA, Inc.
    Inventors: Shawn David Corey, Michael Cleat Bishop, II